Trademark: 90906331
Status Date
Thursday, March 21, 2024
Filing Date
Friday, August 27, 2021
Published for Opposition
Tuesday, January 24, 2023
5 Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders
35 Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; business administrative services for medical referrals
44 Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders
42 Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing in the nature of pharmaceutical testing, namely, in vitro and in vivo preclinical testing of potential drugs; and consultation related to all the foregoing services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Mar 22, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2024
Sou Extension 2 Granted
Mar 21, 2024
Sou Extension 2 Filed
Mar 21, 2024
Sou Teas Extension Received
Aug 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 22, 2023
Sou Extension 1 Granted
Aug 22, 2023
Sou Extension 1 Filed
Aug 22, 2023
Sou Teas Extension Received
Mar 21, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 20, 2022
Approved For Pub - Principal Register
Dec 20, 2022
Examiner's Amendment Entered
Dec 20, 2022
Notification Of Examiners Amendment E-Mailed
Dec 20, 2022
Examiners Amendment E-Mailed
Dec 20, 2022
Examiners Amendment -Written
Nov 30, 2022
Examiner's Amendment Entered
Nov 30, 2022
Notification Of Examiners Amendment E-Mailed
Nov 30, 2022
Examiners Amendment E-Mailed
Nov 30, 2022
Examiners Amendment -Written
Jun 17, 2022
Teas Change Of Correspondence Received
Jun 17, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 17, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 1, 2022
Notification Of Non-Final Action E-Mailed
Jun 1, 2022
Non-Final Action E-Mailed
Jun 1, 2022
Non-Final Action Written
Jun 1, 2022
Assigned To Examiner
Sep 30, 2021
New Application Office Supplied Data Entered
Aug 31, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
